Elizabeth M. Bebin

Electroencephalographic Transient Beta Event Rates in Autism and Related Neurogenetic Conditions.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

From Infancy to Early School Age: Longitudinal Developmental Outcomes and Autism Diagnostic Stability in Tuberous Sclerosis Complex.

Journal: Pediatric neurology

Published: May 07, 2026

Tuberous sclerosis complex.

Journal: Nature reviews. Disease primers

Published: February 16, 2026

Early Vigabatrin Treatment Before Seizure Onset Decreased Interictal Epileptiform Discharges Over the Duration of the PREVeNT Study.

Journal: Pediatric neurology

Published: December 29, 2025

A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complex.

Journal: Computers in biology and medicine

Published: November 17, 2025

Lesions Associated With Autism Symptoms Map to a Cerebellar Brain Network in Tuberous Sclerosis Complex.

Journal: Annals of the Child Neurology Society

Published: September 07, 2025

Early Vocal Development in Tuberous Sclerosis Complex Predicts Language but Not Autism Outcomes.

Journal: Pediatric neurology

Published: August 20, 2025

Electroencephalogram (EEG) Spike Metrics Discriminate Impending Epileptic Spasms From Other Seizures in Children With Tuberous Sclerosis Complex: A Pilot Study.

Journal: Journal of child neurology

Published: July 08, 2025

Neurodevelopmental Outcomes From the PREVeNT Trial.

Journal: Pediatric neurology

Published: March 10, 2025

Developmental Trajectories of Adaptive Functioning and Behavior Problems in Children With Co-Occurring Tuberous Sclerosis Complex and Autism Spectrum Disorder, With and Without Seizures.

Journal: Pediatric neurology

Published: January 14, 2025

Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial Endpoints.

Journal: American journal on intellectual and developmental disabilities

Published: January 07, 2025

Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results.

Journal: Annals of the Child Neurology Society

Published: December 27, 2024

Electroencephalographic Transient Beta Event Rates in Autism and Related Neurogenetic Conditions.

Electroencephalographic Transient Beta Event Rates in Autism and Related Neurogenetic Conditions.

From Infancy to Early School Age: Longitudinal Developmental Outcomes and Autism Diagnostic Stability in Tuberous Sclerosis Complex.

From Infancy to Early School Age: Longitudinal Developmental Outcomes and Autism Diagnostic Stability in Tuberous Sclerosis Complex.

Tuberous sclerosis complex.

Tuberous sclerosis complex.

Early Vigabatrin Treatment Before Seizure Onset Decreased Interictal Epileptiform Discharges Over the Duration of the PREVeNT Study.

Early Vigabatrin Treatment Before Seizure Onset Decreased Interictal Epileptiform Discharges Over the Duration of the PREVeNT Study.

A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complex.

A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complex.

Lesions Associated With Autism Symptoms Map to a Cerebellar Brain Network in Tuberous Sclerosis Complex.

Lesions Associated With Autism Symptoms Map to a Cerebellar Brain Network in Tuberous Sclerosis Complex.

Early Vocal Development in Tuberous Sclerosis Complex Predicts Language but Not Autism Outcomes.

Early Vocal Development in Tuberous Sclerosis Complex Predicts Language but Not Autism Outcomes.

Electroencephalogram (EEG) Spike Metrics Discriminate Impending Epileptic Spasms From Other Seizures in Children With Tuberous Sclerosis Complex: A Pilot Study.

Electroencephalogram (EEG) Spike Metrics Discriminate Impending Epileptic Spasms From Other Seizures in Children With Tuberous Sclerosis Complex: A Pilot Study.

Neurodevelopmental Outcomes From the PREVeNT Trial.

Neurodevelopmental Outcomes From the PREVeNT Trial.

Developmental Trajectories of Adaptive Functioning and Behavior Problems in Children With Co-Occurring Tuberous Sclerosis Complex and Autism Spectrum Disorder, With and Without Seizures.

Developmental Trajectories of Adaptive Functioning and Behavior Problems in Children With Co-Occurring Tuberous Sclerosis Complex and Autism Spectrum Disorder, With and Without Seizures.

Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial Endpoints.

Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial Endpoints.

Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results.

Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results.

A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complex.

A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complex.